Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery.

Abstract
To study the physiology of the high affinity vascular smooth muscle receptor for angiotensin II [A], 125I-A binding sites were characterized in a particulate fraction prepared from rat mesenteric arteries. 125I-A binding was saturable at physiological concentrations of hormone and was of high affinity. Scatchard analysis indicated a single class of binding sites with an Kd of 0.91 .+-. 0.11 (SD) nM, and a total binding capacity of 53.7 .+-. 3.0 f[femto]mol/mg protein. Parallel studies with 3H-A yielded a similar Kd (1.18 .+-. 0.48 nM) and total binding capacity (56.8 .+-. 9.2 fmol/mg protein). 125I-A associated with binding sites rapidly (half-time for association = 4 min at 37.degree. C), and reversibly. Kinetic analysis of binding at 22.degree. C by 2 independent methods yielded comparable values for both the association rate (4.0 and 6.8 .times. 105/M per s) and dissociation rate (3.2 and 3.8 .times. 10-4/s) constants. Kd calculated from kinetic analysis (0.56 and 0.80 nM) were in close agreement with those obtained from steady state Scatchard analysis. Analogs and antagonists of A competed for binding in a potency series which exactly paralleled that observed for bioassay systems utilizing pressor response in vivo and vascular smooth muscle contraction in vitro. 125I-A binding was stimulated 2- to 3-fold in the presence of 1 mM divalent cations (Mn2+ > Mg2+ > Ca2+) and reversibly inhibited by EDTA and ethylene glycol-bis(.beta.-aminoethyl ether)N,N,N'',N''-tetraacetic acid. Dithiothreitol (5 mM), a sulfhydryl-reducing agent that was reported to block vasoconstrictor response to A, inhibited 125I binding by 45%. The present study defines specific A binding sites in a muscular artery representative of the resistance vasculature. These binding sites, unlike those previously described in conductance-type vessels (aorta), apparently have a sufficiently high affinity to interact with physiological levels of hormone.